Aclaris Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.0M | 1.3M | 3.3M | 1.8M | 1.5M | 9.2M | 4.3M | 2.8M |
| Cost of Goods Sold | 395K | -803K | 538K | 1.9M | 506K | 9.3M | 2.4M | 1.9M |
| Gross Profit | 1.6M | 2.1M | 2.8M | -73K | 949K | -90K | 1.9M | 857K |
| R&D Expenses | 15.7M | 16.6M | 13.0M | 11.4M | 11.6M | 9.0M | 6.0M | 8.8M |
| Operating Expenses | 23.8M | 24.8M | 19.9M | 18.3M | 19.0M | 99.6M | 12.4M | 13.7M |
| Operating Income | -22.2M | -22.7M | -17.1M | -18.4M | -18.1M | -99.7M | -10.5M | -12.9M |
| Other Income / Gains | 2.4M | 2.9M | 2.5M | 3.0M | 3.0M | 3.1M | 2.9M | 1.9M |
| Net Income | -19.8M | -19.8M | -14.6M | -15.4M | -15.1M | -96.6M | -7.6M | -11.0M |
| EPS (Diluted) | -0.15 | -0.16 | -0.12 | -0.13 | -0.12 | -1.01 | -0.11 | -0.15 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.802 | 1.62 | 0.837 | -0.041 | 0.652 | -0.01 | 0.446 | 0.31 |
| General And Administrative Expenses | 6.7M | 5.6M | 4.9M | 5.4M | 6.1M | 5.0M | 5.7M | 4.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -100K |
| Selling General And Administrative Expenses | 6.7M | 5.6M | 4.9M | 5.4M | 6.1M | 5.0M | 5.7M | 4.7M |
| Other Expenses | 1.4M | 2.7M | 2.0M | 1.5M | 1.3M | 85.6M | 800K | 300K |
| Cost And Expenses | 24.2M | 24.0M | 20.4M | 20.2M | 19.5M | 108.9M | 14.8M | 15.6M |
| Interest Income | 1.5M | 1.6M | 1.8M | 2.0M | 2.2M | 2.1M | 2.0M | 1.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 102K | 102K | 210K | 114K | 128K | 143K | 179K | 42K |
| Ebitda | -19.7M | -19.7M | -14.4M | -16.8M | -17.7M | -13.9M | -9.5M | -12.6M |
| Ebitdaratio | -9.881 | -15.207 | -4.366 | -9.451 | -12.135 | -1.512 | -2.184 | -4.56 |
| Operating Income Ratio | -11.118 | -17.555 | -5.198 | -10.359 | -12.429 | -10.821 | -2.409 | -4.647 |
| Income Before Tax | -19.8M | -19.8M | -14.6M | -15.4M | -15.1M | -96.6M | -7.6M | -11.0M |
| Income Before Tax Ratio | -9.932 | -15.286 | -4.43 | -8.683 | -10.368 | -10.482 | -1.746 | -3.972 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -9.932 | -15.286 | -4.43 | -8.683 | -10.368 | -10.482 | -1.746 | -3.972 |
| Epsdiluted | -0.15 | -0.16 | -0.12 | -0.13 | -0.12 | -1.01 | -0.11 | -0.15 |
| Weighted Average Shs Out | 128.8M | 122.7M | 122.6M | 122.6M | 122.4M | 95.3M | 71.4M | 71.3M |
| Weighted Average Shs Out Dil | 128.8M | 122.7M | 122.6M | 122.6M | 122.4M | 95.3M | 71.4M | 71.3M |